Cited by 1,240Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental DisordersGenomics and Rare Diseases

Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders

Open access
O’Roak, Brian J., Vives, Laura, Fu, Wenqing, Egertson, Jarrett D., Stanaway, Ian B., Phelps, Ian G., Carvill, Gemma, Kumar, Akash +18 more·2012·Science

Abstract

Autism Genes, Again and Again: Despite recent advances in sequencing technologies and their lowered costs—effective, highly sensitive, and specific sequencing of multiple genes of interest from large cohorts remains expensive. O'Roak et al. (p. 1619 ; published online 15 November) modified molecular inversion probe methods for target-specific capture and sequencing to resequence candidate genes in thousands of patients. The technique was applied to 44 candidate genes to identify de novo mutations in a large cohort of individuals with and without autism spectrum disorder. The analysis revealed several de novo mutations in genes that together contribute to 1% of sporadic autism spectrum disorders, supporting the notion that multiple genes underlie autism-spectrum disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.1227764

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Targeted sequencing of genes in that subnetwork in a larger cohort found more risk variants than expected by chance, showing PPI connectivity can predict ASD risk mutations.

    “Genes in this subnetwork were evaluated in a larger cohort in a targeted sequencing study120, which identified more risk variants compared with chance and demonstrated that PPI connectivity can be a predictor of ASD risk mutations.”
  • CHD8 is the gene most frequently affected by ASD-associated rare de novo variation.

    “chromodomain helicase DNA-binding protein 8 (CHD8)118, which is the gene most frequently affected by ASD-associated rare de novo variation72,119–121.”
  • DYRK1A has three truncating mutations in autism probands and de novo structural variants in ID probands.

    “Another striking candidate is DYRK1A (dual-specificity tyrosine phosphorylation-regulated kinase 1A), for which three truncating mutations have been discovered in autism probands [24,44] and de novo structural variants in ID probands [54,55].”
  • MIP resequencing of 44 candidate genes in 2446 ASD probands yielded 27 new de novo mutations across 16 genes, of which 17 were disruptive SNVs, a fraction higher than expected by chance.

    “Altogether, this assay yielded 27 new de novo mutations across 16 genes; of these mutations, 17 were disruptive SNVs, a fraction higher than expected by chance.”
  • CHD8 has the strongest overall association, with eight de novo truncating mutations observed across 2597 cases and none in control siblings or over 6500 ESP exomes.

    “Overall, eight de novo truncating mutations were observed across 2597 cases in this gene; by contrast, no such mutations were observed in control siblings, or in over 6500 exomes in the ESP.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [26]Krumm N NHLBI Exome Sequencing Project, Copy number variation detection and genotyping from exome sequence data Genome Res 22 1525 2012 10.1101/gr.138115.112 22585873 PMC3409265 · DOI
  2. [52]Wei X NISC Comparative Sequencing Program, Exome sequencing identifies GRIN2A as frequently mutated in melanoma Nat Genet 43 442 2011 10.1038/ng.810 21499247 PMC3161250 · DOI
  3. [65]Nord AS STAART Psychopharmacology Network, Reduced transcript expression of genes affected by inherited and de novo CNVs in autism Eur J Hum Genet 19 727 2011 10.1038/ejhg.2011.24 21448237 PMC3110052 · DOI

Cited by

Sorted by citations

Authors
O’Roak, B. J., Vives, L., Fu, W., Egertson, J. D., Stanaway, I. B., Phelps, I. G., Carvill, G., Kumar, A., Lee, C., Ankenman, K., Munson, J., Hiatt, J. B., Turner, E. H., Levy, R., O’Day, D. R., Krumm, N., Coe, B. P., Martin, B. K., Borenstein, E., Nickerson, D. A., Mefford, H. C., Doherty, D., Akey, J. M., Bernier, R., Eichler, E. E., & Shendure, J.
Affiliations
  • University of Washington (US)
  • Seattle Children's Hospital (US)
  • Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA 98195, USA.
  • Santa Fe Institute (US)
  • Howard Hughes Medical Institute (US)
Corresponding author
  • Eichler, Evan E.
  • Shendure, Jay
Venue
Science
Published
2012-12-21
Volume
338
Issue
6114
Pages
1619-1622
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W1988670106
Cited by
1,240
References
93
Citations by year
2026: 24 · 2025: 32 · 2024: 55 · 2023: 61 · 2022: 85 · 2021: 101 · 2020: 91 · 2019: 111 · 2018: 96 · 2017: 124 · 2016: 124 · 2015: 117 · 2014: 133 · 2013: 78 · 2012: 1
FWCI
53.93
Type
journal article
Language
en
Open access
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Howard Hughes Medical Institute
  • National Institutes of Health (1rc2hl103010-01)
  • National Heart, Lung, and Blood Institute (HL 102923, RC2HL102925, HL-102924, HL-102925, RC2HL102926, RC2HL102923, UC2HL102924, RC2HL-103010, UC2HL102925, HL 103010, UC2HL102923, UC2HL103010, RC2HL102924, UC2HL102926, HL-102926)
  • National Institute of Neurological Disorders and Stroke (R56NS069605, R01NS064077, R01NS069605, NS069605)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD065285, R01HD065285)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
autism spectrum disorder, recurrent mutations, de novo mutations, molecular inversion probes, CHD8, DYRK1A, NR2B subunit, Tbr1, PTEN, TBL1XR1, macrocephaly, microcephaly, β-catenin, chromatin remodeling, gene disruption, splicing disruption
MeSH terms
Dyrk Kinases, Cephalometry, Child, Child Development Disorders, Pervasive, Child, Preschool, DNA-Binding Proteins, Female, Humans, Male, Microcephaly, Mutation, Nuclear Proteins, Protein-Tyrosine Kinases, Repressor Proteins, Transcription Factors, Cohort Studies, DNA Probes, Receptors, N-Methyl-D-Aspartate, Protein Serine-Threonine Kinases, Sequence Analysis, DNA, Receptors, Cytoplasmic and Nuclear, Genetic Predisposition to Disease, T-Box Domain Proteins, Chromatin Assembly and Disassembly, PTEN Phosphohydrolase, beta Catenin, Genetic Association Studies, Megalencephaly, Exome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review